An Example of Personalized Treatment in HR+ HER2+ Long Survivor Breast Cancer Patient (Case Report)

Background. Personalized therapy is becoming increasingly popular in oncological scenarios, not only based on molecular pharmacological targets, but also preventing any drug–drug–gene interaction (DDGI), which could lead to severe toxicities. Single nucleotide polymorphisms (SNPs), the individual ge...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Martina Panebianco, Beatrice Taurelli Salimbeni, Michela Roberto, Paolo Marchetti
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2021-05-01
Ráidu:	Current Oncology
Fáttát:	hormone receptor positive (HR+) HER2+ breast cancer drug-drug-gene interaction (DDGI) single nucleotide polymorphisms (SNPs)
Liŋkkat:	https://www.mdpi.com/1718-7729/28/3/184
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!